180 related articles for article (PubMed ID: 20728484)
1. Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design.
Murthy SN; Sammeta SM; Bowers C
J Control Release; 2010 Dec; 148(2):197-203. PubMed ID: 20728484
[TBL] [Abstract][Full Text] [Related]
2. Magnetophoresis in combination with chemical enhancers for transdermal drug delivery.
Sammeta SM; Repka MA; Narasimha Murthy S
Drug Dev Ind Pharm; 2011 Sep; 37(9):1076-82. PubMed ID: 21449699
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
Zhu X; Li F; Peng X; Zeng K
Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
[TBL] [Abstract][Full Text] [Related]
4. [In vitro transdermal permeation of lidocaine-dodecanol binary eutectic system].
Ke GM; Wang L; Wang P; Lu WL; Wang SM; Zhang Q; Guo HY
Yao Xue Xue Bao; 2005 Aug; 40(8):764-8. PubMed ID: 16268515
[TBL] [Abstract][Full Text] [Related]
5. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
Panda A; Sharma PK; Narasimha Murthy S
AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
[TBL] [Abstract][Full Text] [Related]
6. In vivo stratum corneum distribution of lidocaine, assessed by tape stripping, from a new bioadhesive film.
Padula C; Fulgoni A; Santi P
Skin Res Technol; 2010 Feb; 16(1):125-30. PubMed ID: 20384891
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
Miwa Y; Hamamoto H; Ishida T
Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
[TBL] [Abstract][Full Text] [Related]
8. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior.
Padula C; Colombo G; Nicoli S; Catellani PL; Massimo G; Santi P
J Control Release; 2003 Mar; 88(2):277-85. PubMed ID: 12628334
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chemical enhancers in the transdermal delivery of lidocaine.
Lee PJ; Ahmad N; Langer R; Mitragotri S; Prasad Shastri V
Int J Pharm; 2006 Feb; 308(1-2):33-9. PubMed ID: 16321488
[TBL] [Abstract][Full Text] [Related]
10. Design and Development of Lidocaine Microemulsions for Transdermal Delivery.
Wang Y; Wang X; Wang X; Song Y; Wang X; Hao J
AAPS PharmSciTech; 2019 Jan; 20(2):63. PubMed ID: 30627930
[TBL] [Abstract][Full Text] [Related]
11. Transdermal drug delivery enhanced by low voltage electropulsation (LVE).
Sammeta SM; Vaka SR; Murthy SN
Pharm Dev Technol; 2009; 14(2):159-64. PubMed ID: 19519188
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
Wang Y; Wang S; Shi P
Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
[TBL] [Abstract][Full Text] [Related]
13. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
14. Aerosol OT microemulsions as carriers for transdermal delivery of hydrophobic and hydrophilic local anesthetics.
Junyaprasert VB; Boonme P; Wurster DE; Rades T
Drug Deliv; 2008 Jun; 15(5):323-30. PubMed ID: 18763163
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Drug Delivery Kinetics to Epidermal Targets In Vivo.
Hoppel M; Tabosa MAM; Bunge AL; Delgado-Charro MB; Guy RH
AAPS J; 2021 Mar; 23(3):49. PubMed ID: 33782803
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine Transdermal Patch: Pharmacokinetic Modeling and In Vitro-In Vivo Correlation (IVIVC).
Kondamudi PK; Tirumalasetty PP; Malayandi R; Mutalik S; Pillai R
AAPS PharmSciTech; 2016 Jun; 17(3):588-96. PubMed ID: 26283198
[TBL] [Abstract][Full Text] [Related]
17. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.
Zhang L; Wang J; Chi H; Wang S
Drug Deliv; 2016 Nov; 23(9):3529-3537. PubMed ID: 27340888
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R; Bokalial R; Sharma P; Khandavilli S
Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
[TBL] [Abstract][Full Text] [Related]
19. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
[TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
